{"protocolSection":{"identificationModule":{"nctId":"NCT02953405","orgStudyIdInfo":{"id":"DW_CLO001"},"organization":{"fullName":"Daewoong Pharmaceutical Co. LTD.","class":"INDUSTRY"},"briefTitle":"Prescription and Persistence of Antithrombotic Agents in Acute Ischemic Stroke or Transient Ischemic Attack Patients With MCA(Middle Cerebral Artery) Disease"},"statusModule":{"statusVerifiedDate":"2016-10","overallStatus":"UNKNOWN","lastKnownStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2015-12"},"primaryCompletionDateStruct":{"date":"2018-11","type":"ESTIMATED"},"completionDateStruct":{"date":"2018-11","type":"ESTIMATED"},"studyFirstSubmitDate":"2016-10-25","studyFirstSubmitQcDate":"2016-11-01","studyFirstPostDateStruct":{"date":"2016-11-02","type":"ESTIMATED"},"lastUpdateSubmitDate":"2016-11-01","lastUpdatePostDateStruct":{"date":"2016-11-02","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Daewoong Pharmaceutical Co. LTD.","class":"INDUSTRY"}},"descriptionModule":{"briefSummary":"Prescription and Persistence of Antithrombotic agents in Acute Ischemic Stroke or Transient Ischemic Attack Patients with MCA(Middle Cerebral Artery) Disease."},"conditionsModule":{"conditions":["MCA - Middle Cerebral Artery Dissection"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":false,"designInfo":{"observationalModel":"COHORT","timePerspective":"PROSPECTIVE"},"enrollmentInfo":{"count":1000,"type":"ESTIMATED"}},"armsInterventionsModule":{"interventions":[{"type":"DRUG","name":"Clopidogrel"}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Prescription status of Antithrombotic Agents","timeFrame":"at 12 months after baseline(onset)"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* 19 years later, men and women\n\nExclusion Criteria:\n\n* Subject who is judged to be ineligible by investigator","healthyVolunteers":false,"sex":"ALL","minimumAge":"19 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"Prescription and Persistence of Antithrombotic Agents in Acute Ischemic Stroke or Transient Ischemic Attack Patients With MCA(Middle Cerebral Artery) Disease","samplingMethod":"PROBABILITY_SAMPLE"},"contactsLocationsModule":{"locations":[{"facility":"SNUBH","status":"RECRUITING","city":"Seoul","country":"Korea, Republic of","contacts":[{"name":"Daewoong Clinical","role":"CONTACT","phone":"82-2-550-8800"}],"geoPoint":{"lat":37.566,"lon":126.9784}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","relevance":"LOW"},{"id":"M5485","name":"Ischemic Attack, Transient","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]},"interventionBrowseModule":{"meshes":[{"id":"D000077144","term":"Clopidogrel"}],"ancestors":[{"id":"D000010975","term":"Platelet Aggregation Inhibitors"},{"id":"D000058921","term":"Purinergic P2Y Receptor Antagonists"},{"id":"D000058919","term":"Purinergic P2 Receptor Antagonists"},{"id":"D000058914","term":"Purinergic Antagonists"},{"id":"D000058905","term":"Purinergic Agents"},{"id":"D000018377","term":"Neurotransmitter Agents"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"},{"id":"D000045505","term":"Physiological Effects of Drugs"}],"browseLeaves":[{"id":"M1669","name":"Clopidogrel","asFound":"Results","relevance":"HIGH"},{"id":"M8163","name":"Fibrinolytic Agents","relevance":"LOW"},{"id":"M13555","name":"Platelet Aggregation Inhibitors","relevance":"LOW"},{"id":"M28984","name":"Purinergic P2Y Receptor Antagonists","relevance":"LOW"},{"id":"M20194","name":"Neurotransmitter Agents","relevance":"LOW"}],"browseBranches":[{"abbrev":"PlAggInh","name":"Platelet Aggregation Inhibitors"},{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"FiAg","name":"Fibrinolytic Agents"}]}},"hasResults":false}